Surmodics, Inc. - Common Stock (NQ:SRDX)

42.98 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Surmodics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

November 18, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.

Via Chartmill

On Monday, there are stocks with unusual volume. Let's take a look. ↗

November 17, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

November 17, 2025

From Surmodics, Inc.

Via Business Wire

What's Next: Surmodics's Earnings Preview ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

A Look at Surmodics's Upcoming Earnings Report ↗

April 29, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

November 11, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗

November 11, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge ↗

November 11, 2025

A U.S. court denied the FTC's bid to block GTCR's $627 million acquisition of Surmodics, clearing the way for the merger to proceed.

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 11, 2025

The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗

November 11, 2025

Via Benzinga

US Stocks Mixed; Sea Shares Gain After Q3 Results ↗

November 11, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's pre-market session. ↗

November 11, 2025

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

Via Chartmill

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

November 10, 2025

From Surmodics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

November 04, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

November 03, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform

October 29, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics Announces PROWL Registry Sex-Specific Data to be Presented at TCT Conference on October 28

October 27, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics Inc (NASDAQ:SRDX) Beats Q3 Earnings Estimates Despite Revenue Challenges, Raises Full-Year Guidance ↗

August 08, 2025

Surmodics Inc (SRDX) beats Q3 earnings estimates with $0.06 EPS, raises FY2025 guidance. Revenue dips 3% but Pounce Thrombectomy grows 35%. Shares rise on improved profitability.

Via Chartmill

Surmodics (SRDX) Q3 EPS Turns Positive ↗

August 08, 2025

Via The Motley Fool

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

August 08, 2025

From Surmodics, Inc.

Via Business Wire

Earnings Scheduled For August 8, 2025 ↗

August 08, 2025

Via Benzinga

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

August 06, 2025

From Surmodics, Inc.

Via Business Wire

9 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2025

Via Benzinga

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

April 30, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

April 28, 2025

From Surmodics, Inc.

Via Business Wire

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

April 22, 2025

From Surmodics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.